Indian Chemists’ Strike Seeks Halt To E-Pharmacy Sales
This article was originally published in PharmAsia News
Pharmacies across India staged a one-day shutdown last week to demand a halt to e-pharmacy sales, becoming the latest retail group to oppose a booming online sector that is seen as threatening earnings of traditional bricks-and-mortar stores in the country.
You may also be interested in...
India’s largest online pharmacy 1mg has raised $70m in its biggest funding round so far, led by Swiss investor Corisol with backing from the World Bank’s finance arm IFC. The company is planning a “rapid scale-up” with the aim of being the top integrated healthcare services provider in the country by 2023.
For the last few years, Indian generic companies have been making headlines for all the wrong reasons, rapped by the US Food and Drug Administration over problems ranging from fudged test results to poor-quality manufacturing standards. But lately, the firms have been enjoying a run of good regulatory tidings, giving a fillip to their share prices.
Asia’s biggest biotech company, India’s Biocon Ltd, has announced it will conduct what it says is the first-ever clinical trial of a siRNA therapy in India with US partner Quark, is aimed at tackling a rare eye condition.